Failure of combination chemotherapy of advanced follicular (low-grade) non-Hodgkin's lymphoma

Am J Clin Oncol. 1987 Jun;10(3):196-8. doi: 10.1097/00000421-198706000-00003.

Abstract

Twenty-two patients with Stage III and IV follicular non-Hodgkin's lymphoma were treated for 8 months by a chemotherapy regimen alternating between two different four-drug combinations (doxorubicin, teniposide, cyclophosphamide, prednisone; vincristine, cyclophosphamide, CCNU, prednisone). The overall response rate (complete and partial remission) was 68%. The complete remission rate was 23%. Twenty patients are alive, 50% of them are free of disease progression (median follow-up 76 months). It is concluded that our chemotherapy regimen is not satisfactory and that new therapeutic approaches are needed.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Lomustine / administration & dosage
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / pathology
  • Male
  • Middle Aged
  • Prednisone / administration & dosage
  • Teniposide / administration & dosage
  • Time Factors
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Lomustine
  • Doxorubicin
  • Cyclophosphamide
  • Teniposide
  • Prednisone